SPHERA FUNDS MANAGEMENT LTD.
TEL AVIV, L3 · CIK 1496201 · 13F filing filed 2025-08-14
Exempt reporting adviser since 2021 · other (specify)
- Private funds1 (1 hedge) · $849.7m gross assets
- Websitespherafund.com
- Form ADV · 2026-03-17SEC adviser record
- Legal entityספרה ניהול קרנות בע"מ (IL)
- Kindhedge funds
- Others nearbyTel Aviv
As an employer
- Offices in1 country
- Private fundshedge 1
$382.5m
reported value
-5.7% vs Q1 2025
101positions
34.8%in top 10
16 new
23 added
53 reduced
27 sold out
vs Q1 2025
Options: 7 call positions ($24.9m notional), 2 put positions ($18.7m notional) – listed below, not included above.
This report includes the holdings of 2 other managers that share the investment decisions:
- Sphera Global Healthcare GP Ltd. – reports through this filing
- Sphera Global Healthcare Management LP – reports through this filing
Shares in two reports are counted once in each security's totals.
Holdings, Q2 2025
The small lines show how much was held over the last 4 quarters (adjusted for stock splits).
| Security | Value | Change |
|---|---|---|
| TEVA PHARMACEUTICAL INDS LTD SPONSORED ADS | $27.2m7.10% | Added +48.8k |
| NOVA LTD NVMI | $20.9m5.46% | Reduced -14.9k |
| SYNDAX PHARMACEUTICALS INC SNDX | $14.7m3.85% | Reduced -92.4k |
| TOWER SEMICONDUCTOR LTD TSEM | $11.5m3.00% | Added +203.2k |
| CYTOKINETICS INC CYTK | $10.8m2.82% | Added +181.8k |
| SANOFI SNY | $10.6m2.77% | Reduced -85.0k |
| BIOGEN INC BIIB | $10.4m2.72% | Added +60.0k |
| ASTRAZENECA PLC SPONSORED ADR | $9.4m2.47% | Reduced -40.0k |
| ELI LILLY & CO LLY | $9.0m2.35% | Reduced -150 |
| NVIDIA CORPORATION NVDA | $8.6m2.25% | Added +24.9k |
| CELLDEX THERAPEUTICS INC NEW CLDX | $8.5m2.23% | Reduced -88.3k |
| NOVO-NORDISK A S NVO | $7.3m1.91% | Reduced -12.4k |
| AMAZON COM INC AMZN | $7.1m1.86% | Reduced -4.2k |
| CIDARA THERAPEUTICS INC CDTX | $6.7m1.76% | Added +120.9k |
| ORMAT TECHNOLOGIES INC ORA | $6.5m1.71% | Reduced -6.0k |
| MINERALYS THERAPEUTICS INC MLYS | $6.5m1.70% | Added +15.4k |
| FORTE BIOSCIENCES INC FBRX | $6.4m1.67% | New |
| META PLATFORMS INC META | $6.3m1.65% | Reduced -1.4k |
| JOHNSON & JOHNSON JNJ | $6.2m1.63% | Reduced -12.0k |
| MICROSOFT CORP MSFT | $5.9m1.53% | Added +7.2k |
| AMICUS THERAPEUTICS INC FOLD | $5.7m1.48% | New |
| ORMAT TECHNOLOGIES INC ORA 2.5 07.15.27 SEPT | $5.6m1.47% | Unchanged |
| PHARVARIS N V PHVS | $5.5m1.43% | Reduced -73.9k |
| ELEDON PHARMACEUTICALS INC ELDN | $5.3m1.39% | Reduced -347.5k |
| TRAVERE THERAPEUTICS INC TVTX | $5.0m1.30% | Added +135.3k |
| ABBVIE INC ABBV | $4.7m1.23% | Reduced -5.0k |
| GSK PLC GSK | $4.7m1.22% | Reduced -8.0k |
| PRAXIS PRECISION MEDICINES I PRAX | $4.6m1.21% | Reduced -30.9k |
| NOVARTIS AG NVS | $4.5m1.17% | Reduced -13.0k |
| TREVI THERAPEUTICS INC TRVI | $4.4m1.14% | New |
| MAZE THERAPEUTICS INC MAZE | $4.4m1.14% | Added +899 |
| ANNEXON INC ANNX | $4.2m1.11% | Unchanged |
| IMMUNOVANT INC IMVT | $4.1m1.07% | Added +62.1k |
| ORIC PHARMACEUTICALS INC ORIC | $4.0m1.05% | Added +159.9k |
| MERCK & CO INC MRK | $3.8m1.01% | Reduced -11.0k |
| ACADIA PHARMACEUTICALS INC ACAD | $3.8m0.99% | New |
| BRIDGEBIO PHARMA INC BBIO | $3.8m0.98% | Reduced -279.5k |
| ULTRAGENYX PHARMACEUTICAL IN RARE | $3.6m0.95% | Reduced -167.3k |
| AVIDITY BIOSCIENCES INC RNA | $3.6m0.94% | Added +20.0k |
| ALPHA COGNITION INC ACOG | $3.5m0.92% | Reduced -220.3k |
| REZOLUTE INC RZLT | $3.4m0.88% | Reduced -330.0k |
| CYBIN INC COM NEW | $3.3m0.87% | Reduced -128.9k |
| APPLIED MATLS INC AMAT | $3.3m0.86% | Unchanged |
| ARROWHEAD PHARMACEUTICALS IN ARWR | $3.2m0.84% | Reduced -74.6k |
| IMMATICS N.V IMTX | $3.1m0.82% | Reduced -338.0k |
| SAVARA INC SVRA | $3.0m0.78% | Added +26.1k |
| UBER TECHNOLOGIES INC UBER | $2.8m0.73% | Unchanged |
| SAREPTA THERAPEUTICS INC SRPT | $2.7m0.71% | Added +1.4k |
| CAMTEK LTD CAMT | $2.7m0.71% | Added +8.9k |
| ELBIT SYS LTD ESLT | $2.7m0.71% | New |
| PALO ALTO NETWORKS INC PANW | $2.7m0.70% | New |
| WIX COM LTD WIX | $2.7m0.70% | Added +8.1k |
| AMGEN INC AMGN | $2.7m0.69% | Reduced -500 |
| SOLAREDGE TECHNOLOGIES INC SEDG | $2.6m0.68% | Reduced -181.2k |
| ENLIVEN THERAPEUTICS INC ELVN | $2.6m0.67% | Added +16.8k |
| SKYE BIOSCIENCE INC COM NEW | $2.3m0.59% | Reduced -937.9k |
| DYNE THERAPEUTICS INC DYN | $2.1m0.55% | Reduced -107.8k |
| PFIZER INC PFE | $2.1m0.55% | Reduced -4.0k |
| BIOHAVEN LTD BHVN | $2.1m0.54% | Added +45.6k |
| SCHOLAR ROCK HLDG CORP SRRK | $2.0m0.53% | Reduced -20.7k |
| 89BIO INC ETNB | $2.0m0.53% | Reduced -412.7k |
| STRUCTURE THERAPEUTICS INC GPCR | $2.0m0.52% | Added +11.9k |
| JANUX THERAPEUTICS INC JANX | $2.0m0.52% | Reduced -40.0k |
| APELLIS PHARMACEUTICALS INC APLS | $2.0m0.52% | Reduced -67.0k |
| SALESFORCE INC CRM | $1.9m0.48% | Reduced -2.3k |
| ENGENE HOLDINGS INC COM | $1.8m0.48% | Reduced -24.0k |
| CYBERARK SOFTWARE LTD CYBR | $1.6m0.43% | New |
| MARVELL TECHNOLOGY INC MRVL | $1.4m0.38% | Added +3.7k |
| ASTRIA THERAPEUTICS INC CATB | $1.4m0.36% | Added +67.6k |
| KURA ONCOLOGY INC KURA | $1.4m0.36% | Reduced -108.0k |
| ISHARES BITCOIN TRUST ETF IBIT | $1.3m0.34% | Added +13.3k |
| INTELLIA THERAPEUTICS INC NTLA | $1.2m0.32% | Reduced -252.3k |
| VENTYX BIOSCIENCES INC VTYX | $1.2m0.31% | Reduced -456.9k |
| ADVANCED MICRO DEVICES INC AMD | $1.2m0.31% | New |
| NANO DIMENSION LTD NNDM | $1.2m0.30% | Unchanged |
| DAY ONE BIOPHARMACEUTICALS I COM | $1.1m0.30% | Reduced -159.6k |
| CEVA INC CEVA | $1.1m0.28% | Unchanged |
| PERSPECTIVE THERAPEUTICS INC CATX | $1.1m0.28% | Reduced -149.9k |
| COGENT BIOSCIENCES INC COGT | $1.0m0.27% | Reduced -191.3k |
| KRYSTAL BIOTECH INC KRYS | $1.0m0.26% | New |
| TAYSHA GENE THERAPIES INC TSHA | $970.2k0.25% | New |
| PROMIS NEUROSCIENCES INC PMN | $918.9k0.24% | Reduced -30.0k |
| VISTAGEN THERAPEUTICS INC VTGN | $895.9k0.23% | Reduced -342.6k |
| CHEMOMAB THERAPEUTICS LTD SPONSORED ADS | $856.1k0.22% | Reduced -162.4k |
| BRISTOL-MYERS SQUIBB CO BMY | $810.1k0.21% | Reduced -2.5k |
| CORVUS PHARMACEUTICALS INC CRVS | $732.4k0.19% | Reduced -22.8k |
| WEREWOLF THERAPEUTICS INC HOWL | $683.2k0.18% | Unchanged |
| VERASTEM INC VSTM | $677.7k0.18% | New |
| BICARA THERAPEUTICS INC BCAX | $610.2k0.16% | New |
| LARIMAR THERAPEUTICS INC LRMR | $568.3k0.15% | Reduced -169.7k |
| SENTINELONE INC S | $493.6k0.13% | New |
| APREA THERAPEUTICS INC APRE | $456.3k0.12% | Unchanged |
| COGNYTE SOFTWARE LTD CGNT | $417.5k0.11% | New |
| KEZAR LIFE SCIENCES INC KZR | $268.1k0.07% | Reduced -49.9k |
| CLIMB BIO INC CLYM | $260.2k0.07% | Reduced -32.1k |
| SOLID BIOSCIENCES INC SLDB | $244.4k0.06% | New |
| PEPGEN INC PEPG | $173.7k0.05% | New |
| ONKURE THERAPEUTICS INC OKUR | $144.5k0.04% | Reduced -20.0k |
| ELEVATION ONCOLOGY INC COM | $120.6k0.03% | Reduced -30.0k |
| JASPER THERAPEUTICS INC JSPR | $81.4k0.02% | Reduced -107.3k |
Sold out since Q1 2025
| Security | Value then |
|---|---|
| NICE LTD NICE | $5.1m33.3k shares |
| MERUS N V MRUS | $4.5m106.5k shares |
| VIGIL NEUROSCIENCE INC VIGL | $2.9m1.6m shares |
| WORKDAY INC WDAY | $2.3m10.0k shares |
| SPRINGWORKS THERAPEUTICS INC SWTX | $2.3m52.0k shares |
| ALPHABET INC GOOG | $2.1m13.5k shares |
| VIKING THERAPEUTICS INC VKTX | $2.0m83.3k shares |
| BROADCOM INC AVGO | $2.0m11.7k shares |
| IONIS PHARMACEUTICALS INC IONS | $1.9m63.8k shares |
| NIKE INC NKE | $1.9m30.1k shares |
| CHECK POINT SOFTWARE TECH LT CHKP | $1.9m8.3k shares |
| ROCKET PHARMACEUTICALS INC RCKT | $1.8m271.8k shares |
| NUTRIEN LTD NTR | $1.5m30.9k shares |
| JFROG LTD FROG | $1.4m42.9k shares |
| SHL TELEMEDICINE LTD SHLT | $1.3m632.5k shares |
| INOZYME PHARMA INC | $1.1m1.2m shares |
| OUTLOOK THERAPEUTICS INC OTLK | $1.0m857.1k shares |
| ARVINAS INC ARVN | $877.5k125.0k shares |
| XENON PHARMACEUTICALS INC XENE | $875.6k26.1k shares |
| PERION NETWORK LTD PERI | $835.3k102.6k shares |
| REGULUS THERAPEUTICS INC RGLS | $792.5k452.8k shares |
| VIR BIOTECHNOLOGY INC VIR | $588.7k90.9k shares |
| ZURA BIO LTD ZURA | $543.4k421.2k shares |
| FATE THERAPEUTICS INC FATE | $313.8k397.2k shares |
| ALECTOR INC ALEC | $134.3k109.2k shares |
Options (notional value)
| Underlying | Notional | Change |
|---|---|---|
| SPDR SER TR XBI · Put | $16.6m200.0k shares | New |
| ULTRAGENYX PHARMACEUTICAL IN RARE · Call | $6.6m180.6k shares | Added |
| MOONLAKE IMMUNOTHERAPEUTICS MLTX · Call | $5.9m125.0k shares | New |
| PRAXIS PRECISION MEDICINES I PRAX · Call | $4.2m100.0k shares | Unchanged |
| ISHARES TR TLT · Call | $4.1m47.0k shares | Reduced |
| SAREPTA THERAPEUTICS INC SRPT · Call | $2.6m150.0k shares | New |
| BRIDGEBIO PHARMA INC BBIO · Put | $2.2m49.9k shares | New |
| COGENT BIOSCIENCES INC COGT · Call | $1.4m200.0k shares | New |
| ELEDON PHARMACEUTICALS INC ELDN · Call | $84.6k31.2k shares | New |
Stakes above 5%
Companies where this manager has reported owning more than 5% of a class of shares, on Schedule 13D (may seek influence) or 13G (passive): its latest filing for each, from 19 Dec 2024 on.
| Company | Stake |
|---|---|
| PROMIS NEUROSCIENCES INC PMN · 13G · filed 2026-02-05 | 7.8% |
| TENAX THERAPEUTICS INC TENX · 13G · filed 2026-10-13 | 7.1%≈ $38.8m |